Fc-directed antibody conjugation of magnetic nanoparticles for enhanced molecular targeting

Journal of Innovative Optical Health Sciences

Volumn 2, Issue 4, 2009, Pages 387-396

  Rezaeipoor, Robabeh ^a   John, Renu ^a   Adie, Steven G ^a   Chaney, Eric J ^a   Marjanovic, Marina ^a   Oldenburg, Amy L ^a   Rinne, Stephanie A ^a   Boppart, Stephen A ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b University of Illinois at Urbana Champaign   (United States)

Author keywords

cancer; molecular imaging; Nanoprobe

Indexed keywords

ANTIBODY CONJUGATION; ANTIBODY MOLECULES; CANCER; CELL LINES; EPIDERMAL GROWTH FACTOR RECEPTORS; EXPRESSION LEVELS; FUNCTIONALIZED; MACROPHAGE CELL LINE; MAGNETIC NANOPARTICLES; MOLECULAR IMAGING; MOLECULAR TARGETING; TUMOR ANTIGEN;

ANTIGENS; CELL CULTURE; IRON OXIDES; MACROPHAGES; NANOMAGNETICS; NANOPARTICLES; NANOPROBES;

ANTIBODIES;

EID: 77952391105     PISSN: 17935458     EISSN: 17937205     Source Type: Journal    
DOI: 10.1142/S1793545809000693     Document Type: Article

References (41)

1. E. E. Graves, R. Weissleder, V. Ntziachristos, Fluorescence molecular imaging of small animal tumor model, Current Molecular Medicine 4, 419-430 (2004). (Pubitemid 38787010)
2. D. R. Larson, W. R. Zipfel, R. M. Williams, S. W. Clark, M. P. Bruchez, F. W. Wise, W. W. Webb, Water-soluble quantum dots for multiphoton fluorescence imaging in vivo, Science 300, 1434-1436 (2003). (Pubitemid 36638163)
3. X. H. Gao, Y. Y. Cui, R. M. Levenson, L. W. K. Chung, S. M. Nie, In vivo cancer targeting and imaging with semiconductor quantum dots, Nat. Biotechnol. 22, 969-976 (2004). (Pubitemid 39014473)
4. S. Kim, Y. Y. Lim, E. G. Soltesz, A. M. D. Grand, J. Lee, A. Nakayama, J. A. Parker, T. Mihaljevic, R. Laurence, L. H. Cohn, M. G. Bawendi, J. V. Frangioni, Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping, Nat. Biotechnol. 22, 93-97 (2004). (Pubitemid 38057962)
5. J. Czernin, M. E. Phelps, Positron emission tomography scanning: Current and future applications, Ann. Rev. Med. 53, 89-112 (2002). (Pubitemid 34177873)
6. G. D. Luker, D. Piwnica-Worms, Molecular imaging in vivo with PET and SPECT, Acad. Radiol. 8, 4-14 (2001). (Pubitemid 32674635)
7. P. A. Dayton, D. Pearson, J. Clark, S. Simon, P. A. Schumann, R. Zutshi, T. O. Matsunaga, K. W. Ferrara, Ultrasonic analysis of peptide-and antibodytargeted microbubble contrast agents for molecular imaging of αvβ3-expressing cells, Molecular Imaging 3, 125-134 (2004).
8. J.-H. Lee, Y.-M. Huh, Y.-W. Jun, J.-W. Seo, J.-T. Jang, H.-T. Song, S. Kim, E.-J. Cho, H.-G. Yoon, J.-S. Suh, J. Cheon, Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging, Nat. Med. 13, 95-99 (2007). (Pubitemid 46067392)
9. M. A. Funovics, B. Kapeller, C. Hoeller, H. S. Su, R. Kunstfeld, S. Puig, K. Macfelda, MR imaging of the HER2/neu and 9.2.27 tumor antigens using immunospecific contrast agents, Magn. Reson. Imaging 22, 843-850 (2004). (Pubitemid 38962321)
10. I. H. El-Sayed, X. H. Huang, M. A. El-Sayed, Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: Applications in oral cancer, Nano Lett. 5, 829-834 (2005). (Pubitemid 40749040)
11. S. A. Boppart, A. L. Oldenburg, C. Xu, D. L. Marks, Optical probes and techniques for molecular contrast enhancement in coherence imaging, J. Biomed. Opt. 10, 1-14 (2005).
12. T. M. Lee, F. J. Toublan, S. Sitafalwalla, A. L. Oldenburg, K. S. Suslickm, S. A. Boppart, Engineered microsphere contrast agents for optical coherence tomography, Opt. Lett. 28, 1546-1548 (2003).
13. A. L. Oldenburg, F. J. Toublan, K. S. Suslick, A. Wei, S. A. Boppart, Magnetomotive contrast for in vivo optical coherence tomography, Opt. Exp. 13, 6597-6614 (2005). (Pubitemid 41230884)
14. C. Loo, A. Lowery, N. Halas, J. West, R. Drezek, Immunotargeted nanoshells for integrated cancer imaging and therapy, Nano Lett. 5, 709-711 (2005). (Pubitemid 40609745)
15. N. Desai, V. Trieu, Z. W. Yao, L. Louie, S. Ci, A. Yang, C. Tao, T. De, B. Beals, D. Dykes, P. Noker, R. Yao, E. Labao, M. Hawkins, P. Soon-Shiong, Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel, Clin. Cancer Res. 12, 1317-1324 (2006). (Pubitemid 43342524)
16. R. Weissleder, A. Bogdanov, E. A. Neuwelt, M. Papisov, Long-circulating iron oxides for MR imaging, Adv. Drug Delivery Rev. 16, 321-334 (1995).
17. J. Sinek, H. Frieboes, X. Zheng, V. Cristini, Twodimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles, Biomedical Microdevices 6, 297-309 (2004). (Pubitemid 39545749)
18. B. Schade, S. H. L. Lam, D. Cernea, V. Sanguin-Gendreau, R. D. Cardiff, B. L. Jung, M. Hallett, W. J. Muller, Distinct ErbB-2-coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles, Cancer Res. 67, 7579-7589 (2007).
19. N. W. Shi Kam, M. O'Connell, J. A. Wisdom, H. Dai, Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction, Proc. Natl. Acad. Sci. U. S. A. 102, 11600-11605 (2005). (Pubitemid 41170772)
20. S. J. DeNardo, G. L. DeNardo, L. A. Miers, A. Natarajan, A. R. Foreman, C. Grüettner, G. N. Adamson, R. Ivkov, Development of tumor targeting bioprobes (in-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy, Clin. Cancer Res. 11, 7087-7092 (2005).
21. P. Sharma, S. C. Brown, G. Walter, S. Santra, E. Scott, H. Ichikawa, Y. Fukumori, Gdnanoparticulates: From magnetic resonance imaging to neutron capture therapy, Adv. Powder Techn. 18, 663-698 (2007). (Pubitemid 350112907)
22. N. Nasongkla, E. Bey, J. Ren, H. Ai, C. Khemtong, J. S. Guthi, S.-F. Chin, A. D. Sherry, D. A. Boothman, J. Gao, Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems, Nano Lett. 6, 2427-2430 (2006). (Pubitemid 46076928)
23. X.-H. Peng, X. Qian X, H. Mao, A. Y. Wang, Z. Chen, S. Nie, D. M. Shin, Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy, Intl. J. Nanomedicine 3, 311-321 (2008).
24. Y. X. J. Wang, S. M. Hussain, G. P. Krestin, Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging, European Radiology 11, 2319-2331 (2001). (Pubitemid 33041104)
25. C. C. Berry, S. Wells, S. Charles, G. Aitchison, A. S. G. Curtis, Cell response to dextran-derivatised iron oxide nanoparticles post internalization, Biomaterials 25, 5405-5413 (2004). (Pubitemid 38586755)
26. H. Lee, E. Lee, D. K. Kim, N. K. Jang, Y. Y. Jeong, S. Jon, Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging, J. Am. Chem. Soc. 128, 7383-7389 (2006). (Pubitemid 43849141)
27. A. K. Gupta, M. Gupta, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications, Biomaterials 26, 3995-4021 (2005). (Pubitemid 40044762)
28. J. R. McCarthy, R. Weissleder, Multifunctional magnetic nanoparticles for targeted imaging and therapy, Adv. Drug Delivery Rev. 60, 1241-1251 (2008).
29. D. Simberg, T. Duza, J. H. Park, M. Essler, J. Pilch, L. Zhang, A. M. Derfus, M. Yang, R. M. Hoffman, S. Bhatia, M. J. Sailor, E. Ruoslahti, Biomimetic amplification of nanoparticle homing to tumors, Proc. Nat. Acad. Sci. U. S. A. 104, 932-936 (2007). (Pubitemid 46154714)
30. F. Ibraimi, D. Kriz, M. Lu, L.-O. Hansson, K. Kriz, Rapid one-step whole blood C-reactive protein magnetic permeability immunoassay with monoclonal antibody conjugated nanoparticles as superparamagnetic labels and enhanced sedimentation, Analytical and Bioanalytical Chem. 384, 651-657 (2006). (Pubitemid 43237919)
31. C. Grüttner, K. Müller, J. Teller, F. Westphal, A. Foreman, R. Ivkov, Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy, J. Magnetism and Magnetic Materials 311, 181-186 (2007). (Pubitemid 46401005)
32. E. Okon, D. Pouliquen, P. Okon, Z. V. Kovaleva, T. P. Stepanova, S. G. Lavit, B. N. Kudryavtsev, P. Jallet, Biodegradation of magnetite dextran nanoparticles in the rat: A histologic and biophysical study, Laboratory Investigation 71, 895-903 (1994).
33. H. Pardoe, W. Chua-Anusorn, T. G. St. Pierre, J. Dobson, Detection limits for ferrimagnetic particle concentrations using magnetic resonance imaging based on proton transverse relaxation rate measurements, Physics in Medicine and Biology 48, N89-N95 (2003). (Pubitemid 36410410)
34. J. W. Park, K. Hong, D. B. Kirpotin, G. Colbern, R. Shalaby, J. Baselga, Y. Shao, U. B. Nielsen, J. D. Marks, D. Moore, D. Papahadjopoulos, C. C. Benz, Anti-HER2 immunoliposomes enhanced efficacy attributable to targeted delivery, Clin. Cancer Res. 8, 1172-1181 (2002). (Pubitemid 35177372)
35. J. M. Perez, F. J. Simeone, Y. Saeki, L. Josephson, R. Weissleder, Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media, J. Am. Chem. Soc. 125, 10192-10193 (2003). (Pubitemid 37022228)
36. H. Tada, H. Higuchi, T. M. Wanatabe, N. Ohuchi, In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice, Cancer Res. 67, 1138-1144 (2007).
37. M. B. Wilson, P. K. Nakane, The covalent coupling of proteins to periodate-oxidized sephadex: A new approach to immunoadsorbent preparation, J. Immunol. Methods 12, 171-181 (1976).
38. J. M. C. Luk, A. A. Lindberg, Rapid and sensitive detection of Salmonella (O: 6, 7) by immunomagnetic monoclonal antibody-based assays, J. Immunol. Methods 137, 1-8 (1991).
39. L. X. Tiefenauer, G. Kühne, R. Y. Andres, Antibody-magnetite nanoparticles: In vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging, Bioconjugate Chem. 4, 347-352 (1993).
40. F. Bonneaux, E. Dellacherie, P. Labrude, C. Vigneron, Hemoglobin-dialdehyde dextran conjugates: Improvement of their oxygen-binding properties with anionic groups, J. Protein Chem. 15, 461-465 (1996).
41. S. M. Moghimi, A. C. Hunter, J. C. Murray, Nanomedicine: Current status and future prospects, FA S E B J. 19, 311-330 (2005). (Pubitemid 40316520)